Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2023-08-02 Share Issue/Capital Cha…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Statement of CDIs on issue - RMD 4 pages 22.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and provides detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for July 2023, net differences in securities, and reasons for changes such as transfers and new shares issued under employee plans. The document is a regulatory announcement about the company's securities issued and changes in share capital representation, but it does not contain financial statements, earnings data, or management discussion. It is not a full financial report or earnings release, nor is it a proxy or AGM material. The content fits best with a Share Issue/Capital Change announcement, as it details changes in issued securities and CDIs.
2023-08-02 English
RMD to Report Fourth Quarter Fiscal 2023 Results 1
Earnings Release Classification · 95% confidence The document is a press release announcing the upcoming release date of ResMed's fourth quarter fiscal 2023 earnings report and details about the webcast for discussing the results. It does not contain actual financial data or the earnings results themselves, but rather informs investors and media about when and how the earnings will be reported and discussed. The document length is short (2246 characters), and it serves as an announcement rather than the report or transcript itself. Therefore, it fits the category of an Earnings Release (ER) announcement, which is the initial announcement of quarterly financial results and related webcast information. Q4 2023
2023-07-06 English
Statement of CDIs on issue - RMD 4 pages 22.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and details the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for June 2023, showing changes in securities issued, transfers, and stock options. The content focuses on securities issued and changes in share capital representation rather than financial results, management changes, or regulatory filings. The document length is 3079 characters, which is relatively short but contains substantive data on securities issued and changes. This fits the description of a Share Issue/Capital Change announcement, as it reports on new share issues, stock options, and transfers related to capital structure changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2023-07-05 English
Statement of CDIs on issue - RMD 4 pages 22.6KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and details the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for May 2023, showing changes in securities issued and transfers related to stock options and employee plans. There are no financial statements, earnings data, or management commentary. The document is a securities issuance and share count update rather than a financial report or announcement of voting results. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues and capital changes.
2023-06-05 English
FORM SD 7 pages 55.4KB
Regulatory Filings Classification · 95% confidence The document is a Form SD filed with the SEC, titled 'Specialized Disclosure Report' for ResMed Inc. It specifically addresses conflict minerals disclosure pursuant to Exchange Act Rule 13p-1 for the reporting period January 1 to December 31, 2022. The content includes detailed descriptions of the company's due diligence process, supply chain inquiries, and results related to conflict minerals (3TG). This type of filing is a specialized disclosure report focused on conflict minerals compliance, not a full annual report, audit report, or earnings release. It is a regulatory filing required by the SEC to disclose conflict minerals sourcing information. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification.
2023-05-28 English
Update - Dividend/Distribution - RMD 4 pages 26.1KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Notification of dividend / distribution' and contains detailed information about a dividend payment, including the dividend amount, record date, payment date, currency, withholding tax rates, and exchange rates. It updates a previous announcement regarding the foreign exchange rate for the dividend. The content focuses exclusively on dividend details and payment logistics, without any financial statements or broader financial performance data. This matches the definition of a 'Notice of Dividend Amount' filing, which announces dividend amounts, payment dates, and related details for shareholders.
2023-05-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.